{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:30:47Z","timestamp":1785843047234,"version":"3.56.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"2","funder":[{"DOI":"10.13039\/100000056","name":"National Institute of Nursing Research","doi-asserted-by":"publisher","award":["R01NR017573"],"award-info":[{"award-number":["R01NR017573"]}],"id":[{"id":"10.13039\/100000056","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Due to the difficulty of conducting laboratory testing during the pandemic shelter-in-place orders, the objective of this study was to examine the feasibility and acceptability of conducting home-collected samples for preexposure prophylaxis (PrEP) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) laboratory tests.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a pilot study among patients on PrEP in San Francisco primary care clinics. Individuals on PrEP provided home-collected laboratory samples using dried blood spot for fourth-generation human immunodeficiency virus antigen\/antibody test, serum creatinine, syphilis antibody, and hepatitis C antibody, as needed; 3-site (oropharyngeal, rectal, and urine) swabbing for sexually transmitted infections; and nasopharyngeal swabbing for SARS-CoV-2 polymerase chain reaction. We examined feasibility and acceptability of collecting these laboratory samples using predefined benchmarks to determine feasibility or acceptability.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 92 individuals who consented to participate, 73 (79.3%) mailed back their home-collected kit. Nearly 87.7% noted being extremely to moderately satisfied with the ability to complete the laboratory tests without having to come into a clinic. Approximately 49.3% of participants chose this home-collection method as their first choice for providing laboratory samples. Mean time from collection of samples by the participant to receipt of test results was reduced from the first quarter of the study (17 days) to the last quarter of the study (5 days).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>We report high levels of feasibility and acceptability with the use of home-collected laboratory samples for patients on PrEP. Our results indicate that home-collected laboratory samples for patients on PrEP is a viable option that should be offered as an alternative to clinic-collected laboratory samples.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofab657","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T22:42:00Z","timestamp":1642804920000},"source":"Crossref","is-referenced-by-count":13,"title":["Feasibility and Acceptability of Home-Collected Samples for Human Immunodeficiency Virus Preexposure Prophylaxis and Severe Acute Respiratory Syndrome Coronavirus 2 Laboratory Tests in San Francisco Primary Care Clinics"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3793-5112","authenticated-orcid":false,"given":"Parya","family":"Saberi","sequence":"first","affiliation":[{"name":"Department of Medicine, University of California, San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Ming","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isha","family":"Shrestha","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyman","family":"Scott","sequence":"additional","affiliation":[{"name":"Bridge HIV, San Francisco Department of Public Health, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad","family":"Thorson","sequence":"additional","affiliation":[{"name":"Molecular Testing Labs, Vancouver, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Liu","sequence":"additional","affiliation":[{"name":"Bridge HIV, San Francisco Department of Public Health, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,1,21]]},"reference":[{"key":"2022012603175107300_CIT0001","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.","volume":"363","author":"Grant","year":"2010","journal-title":"N Engl J Med"},{"key":"2022012603175107300_CIT0002","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJMoa1110711","article-title":"Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.","volume":"367","author":"Thigpen","year":"2012","journal-title":"N Engl J Med"},{"key":"2022012603175107300_CIT0003","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":"Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.","volume":"367","author":"Baeten","year":"2012","journal-title":"N Engl J Med"},{"key":"2022012603175107300_CIT0004","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","article-title":"Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.","volume":"381","author":"Choopanya","year":"2013","journal-title":"Lancet"},{"key":"2022012603175107300_CIT0005","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMoa1506273","article-title":"On-demand preexposure prophylaxis in men at high risk for HIV-1 infection.","volume":"373","author":"Molina","year":"2015","journal-title":"N Engl J Med"},{"key":"2022012603175107300_CIT0006","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","article-title":"Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.","volume":"387","author":"McCormack","year":"2016","journal-title":"Lancet"},{"key":"2022012603175107300_CIT0007","doi-asserted-by":"crossref","first-page":"e1002099","DOI":"10.1371\/journal.pmed.1002099","article-title":"Integrated delivery of antiretroviral treatment and pre-exposure prophylaxis to HIV-1-serodiscordant couples: a prospective implementation study in Kenya and Uganda.","volume":"13","author":"Baeten","year":"2016","journal-title":"PLoS Med"},{"key":"2022012603175107300_CIT0008","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/QAI.0000000000001179","article-title":"An HIV preexposure prophylaxis demonstration project and safety study for young MSM.","volume":"74","author":"Hosek","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2022012603175107300_CIT0009","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/jamainternmed.2015.4683","article-title":"Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health services.","volume":"176","author":"Liu","year":"2016","journal-title":"JAMA Intern Med"},{"key":"2022012603175107300_CIT0010","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/cid\/cix593","article-title":"Redefining human immunodeficiency virus (HIV) preexposure prophylaxis failures.","volume":"65","author":"Marcus","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2022012603175107300_CIT0011","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.15585\/mmwr.mm6848e1","article-title":"Vital signs: status of human immunodeficiency virus testing, viral suppression, and HIV preexposure prophylaxis\u2014United States, 2013-2018.","volume":"68","author":"Harris","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2022012603175107300_CIT0012","doi-asserted-by":"crossref","first-page":"e0249740","DOI":"10.1371\/journal.pone.0249740","article-title":"Widespread closure of HIV prevention and care services places youth at higher risk during the COVID-19 pandemic.","volume":"16","author":"Stephenson","year":"2021","journal-title":"PLoS One"},{"key":"2022012603175107300_CIT0013","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.15585\/mmwr.mm6936a4","article-title":"Delay or avoidance of medical care because of COVID-19-related concerns\u2014United States, June 2020.","volume":"69","author":"Czeisler","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2022012603175107300_CIT0014","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1007\/s10461-020-02894-2","article-title":"Characterizing the impact of COVID-19 on men who have sex with men across the United States in April, 2020.","volume":"24","author":"Sanchez","year":"2020","journal-title":"AIDS Behav"},{"key":"2022012603175107300_CIT0015","author":"Centers for Disease Control and Prevention.","year":"2018"},{"key":"2022012603175107300_CIT0016","doi-asserted-by":"crossref","first-page":"e0210791","DOI":"10.1371\/journal.pone.0210791","article-title":"Feasibility and acceptability of novel methods to estimate antiretroviral adherence: a longitudinal study.","volume":"14","author":"Saberi","year":"2019","journal-title":"PLoS One"},{"key":"2022012603175107300_CIT0017","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1007\/s10461-020-02868-4","article-title":"Research in the time of coronavirus: continuing ongoing studies in the midst of the COVID-19 pandemic.","volume":"24","author":"Saberi","year":"2020","journal-title":"AIDS Behav"},{"key":"2022012603175107300_CIT0018","doi-asserted-by":"crossref","first-page":"e040734","DOI":"10.1136\/bmjopen-2020-040734","article-title":"Improving the HIV PrEP continuum of care using an intervention for healthcare providers: a stepped-wedge study protocol.","volume":"10","author":"Ming","year":"2020","journal-title":"BMJ Open"},{"key":"2022012603175107300_CIT0019","author":"Molecular Testing Labs.","year":"2021"},{"key":"2022012603175107300_CIT0020","author":"Brooke","year":"1986"},{"key":"2022012603175107300_CIT0021","doi-asserted-by":"crossref","first-page":"e0240745","DOI":"10.1371\/journal.pone.0240745","article-title":"\u201cYou can\u2019t have a PrEP program without a PrEP coordinator\u201d: implementation of a PrEP panel management intervention.","volume":"15","author":"Saberi","year":"2020","journal-title":"PLoS One"},{"key":"2022012603175107300_CIT0022","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/cid\/ciy529","article-title":"Developing and assessing the feasibility of a home-based preexposure prophylaxis monitoring and support program.","volume":"68","author":"Siegler","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2022012603175107300_CIT0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13178-015-0212-y","article-title":"Recruiting a US national sample of HIV-negative gay and bisexual men to complete at-home self-administered HIV\/STI testing and surveys: challenges and opportunities.","volume":"13","author":"Grov","year":"2016","journal-title":"Sex Res Soc Policy"},{"key":"2022012603175107300_CIT0024","doi-asserted-by":"crossref","first-page":"101037","DOI":"10.1016\/j.bjid.2020.11.002","article-title":"High acceptability of PrEP teleconsultation and HIV self-testing among PrEP users during the COVID-19 pandemic in Brazil.","volume":"25","author":"Hoagland","year":"2021","journal-title":"Braz J Infect Dis"},{"key":"2022012603175107300_CIT0025","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/QAI.0000000000001873","article-title":"PrEPTECH: a telehealth-based initiation program for HIV pre-exposure prophylaxis in young men of color who have sex with men. A pilot study of feasibility.","volume":"80","author":"Refugio","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2022012603175107300_CIT0026","doi-asserted-by":"crossref","first-page":"e0189794","DOI":"10.1371\/journal.pone.0189794","article-title":"Home-based pre-exposure prophylaxis (PrEP) services for gay and bisexual men: an opportunity to address barriers to PrEP uptake and persistence.","volume":"12","author":"John","year":"2017","journal-title":"PLoS One"},{"key":"2022012603175107300_CIT0027","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1097\/QAI.0b013e3181e1e2c0","article-title":"Barriers to adolescents\u2019 participation in HIV biomedical prevention research.","volume":"54","author":"DiClemente","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2022012603175107300_CIT0028","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/QAI.0000000000001497","article-title":"Challenges in translating PrEP interest into uptake in an observational study of young black MSM.","volume":"76","author":"Rolle","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2022012603175107300_CIT0029","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/cid\/ciz894","article-title":"Pre-exposure prophylaxis uptake and discontinuation among young black men who have sex with men in Atlanta, Georgia: a prospective cohort study.","volume":"71","author":"Serota","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2022012603175107300_CIT0030","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1007\/s12325-020-01295-0","article-title":"Barriers to the wider use of pre-exposure prophylaxis in the United States: a narrative review.","volume":"37","author":"Mayer","year":"2020","journal-title":"Adv Ther"},{"key":"2022012603175107300_CIT0031","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1001\/jamapediatrics.2020.0824","article-title":"HIV preexposure prophylaxis among adolescents in the US: a review.","volume":"174","author":"Yusuf","year":"2020","journal-title":"JAMA Pediatr"},{"key":"2022012603175107300_CIT0032","author":"Centers for Disease Control and Prevention.","year":"2020"},{"key":"2022012603175107300_CIT0033","author":"National Alliance of State and Territorial AIDS Directors.","year":"2021"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofab657\/42256920\/ofab657.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/9\/2\/ofab657\/42274193\/ofab657.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/9\/2\/ofab657\/42274193\/ofab657.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T03:18:23Z","timestamp":1643167103000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofab657\/6513562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,21]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofab657","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,2,1]]},"published":{"date-parts":[[2022,1,21]]},"article-number":"ofab657"}}